Relapsed Cutaneous T Cell Lymphom
1 clinical trials · Condition
◉ Watch Relapsed Cutaneous T Cell Lymphom
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Study of PLM60 for the Treatment of Cutaneous T Cell Lymphomas (NCT02597153) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2015-10-01 |
Track Relapsed Cutaneous T Cell Lymphom automatically
Every clearance here is in the API, with alerts when new ones post.